Last reviewed · How we verify

NCT03207919

The Lullaby Project: A Musical Intervention for Pregnant Women

Completed NA Last updated 24 April 2018
What this trial tests

NA trial testing Lullaby Project in Pregnancy Related in 44 participants. Completed in 15 May 2017.

Timeline
4 November 2016
Primary endpoint
15 May 2017
15 May 2017

Quick facts

Lead sponsorVirginia Commonwealth University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment44
Start date4 November 2016
Primary completion15 May 2017
Estimated completion15 May 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Virginia Commonwealth University

Who can join

18 and older, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the potential impact of a brief musical intervention, the Lullaby Project, in a sample of pregnant women. The study aims are: 1. To determine the potential effect of the Lullaby Project on maternal-fetal attachment. 2. To evaluate the potential impact of the Lullaby Project on maternal mental health. 3. To characterize the potential impact of the Lullaby Project on perceived maternal stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lullaby Project

Trials testing the same drug.

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other Virginia Commonwealth University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03207919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing